IL-5 activity has been demonstrated to inversely correlate with pulmonary function in patients with asthma [4], and anti-IL-5 treatment has been shown to improve asthma control in patients with severe asthma and eosinophilia [6]. This evidence concerns the gene IL5 and Increased total eosinophil count.